FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068638 [Registered on: 10/06/2024] Trial Registered Prospectively
Last Modified On: 31/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A clinical trial on Poora Maathirai in the management of Uthiravatha suronitham (Rheumatoid Arthritis) among patients attending OPD and IPD of Government Siddha Medical College and Hospital, Palayamkottai  
Scientific Title of Study   A Prospective, open labelled, single arm, non randomized, single centric, phase II, Clinical trail to determine the effectiveness of Poora Maathirai in the management of Uthiravatha suronitham (Rheumatoid arthritis) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  JANARTHANAN A 
Designation  PG scholar 
Affiliation  Government Siddha Medical College and Hospital palayamkottai 
Address  OP number 10, PG department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai, Tirunelveli, India
Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  7010614052  
Fax    
Email  janarthanan4797@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S Uma Kalyani 
Designation  Lecturer grade II 
Affiliation  Government Siddha Medical College and Hospital palayamkottai 
Address  OP number 10, PG department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai, Tirunelveli, India
Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  8072685509  
Fax    
Email  sukgsmc2014@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr T Komalavalli Alias Mehala 
Designation  Head Of the Department 
Affiliation  Government Siddha Medical College and Hospital palayamkottai 
Address  OP number 10, PG department of Pothu Maruthuvam,Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai, India
Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  9788122691  
Fax    
Email  komalaarumugam1@gmail.com  
 
Source of Monetary or Material Support  
OPD and IPD facilities and central library of government siddha medical college and hospital, Tiruvananthapuram mail road,Palayamkottai, Tirunelveli-627002, Tamilnadu, India  
 
Primary Sponsor  
Name  GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI 
Address  PG DEPARTMENT OF POTHU MARUTHUVAM, GOVERNMENT SIDDHA MEDICAL COLLEGE, TIRUVANANTHAPURAM MAIN ROAD, PALAYAMKOTTAI, TIRUNELVELI 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
JANARTHANAN A  Government Siddha Medical College and Hospital   PG department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai, India
Tirunelveli
TAMIL NADU 
7010614052

janarthanan4797@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee,Government Siddha Medical College and Hospital, Palayamkottai   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M057||Rheumatoid arthritis with rheumatoid factor without organ or systems involvement,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  Poora Maathirai  DOSAGE: 1 to 2 Tablets(Twice a day orally) 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Pain and early morning stiffness
2.Those who are willing to participate in this study
3.RA factor test – positive
4.Anti CCP – positive
5.CRP above 20 mg/L
6.ESR elevated
7.ANA TEST in few selected cases
 
 
ExclusionCriteria 
Details  1.Other degenerating joint diseases - osteoarthritis, sero negative spondylo arthritis, ankylosing spondylitis
2.Infectious joint diseases like, Tuberculosis, chronic poly arthritis in chickungunia viral infection.
3.Metabolic joint diseases like gout.
4.Patient who is on DMARD. (eg: methotrexate)
5.Pregnancy and lactating mother.
6.Chronic renal & liver disease patients
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The outcome will be aimed at reducing the symptoms of Uthiravatha suronitham (Rheumatoid Arthiritis) and to determine the efficacy of Poora Maathirai  48 days 
 
Secondary Outcome  
Outcome  TimePoints 
1.To collect various Siddha literatures & modern journals for literature review on Uthiravatha suronitham.
2.To perform physicochemical, phytochemical, bio chemical analysis of Poora Maathirai.
3.To evaluate safety profile for acute & sub-acute toxicity of Poora Maathirai
4.To evaluate pharmacological activities of Poora Maathirai.
5.To study other cofactors related to disease like age, sex, dietary habits, family history, & socioeconomic status.
6.To study about the prevalence of Uthiravatha suronitham relation with diet & lifestyle.
7.To evaluate Siddha parameters (including Envagai thervu, Neerkuri-Neikuri) in Uthiravatha suronitham during trial period.
8.To evaluate dhegi of Uthiravatha suronitham patients.
9.To evaluate modern parametric changes in Uthiravatha suronitham.
10.To assess the quality of life of Uthiravatha suronitham patients.
11.To document Bio statistical analysis. 
6 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   25/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is A Prospective, open labelled, single arm, non randomized, single centric, phase II, Clinical trail to determine the effectiveness of Poora Maathirai in the management of Uthiravatha suronitham (Rheumatoid arthiritis). After purification of trial drugs,  Poora maathirai will be prepared and administered at the dosage of 1 to 2 tablets for 48 days for 40 Rheumatoid Arthritis patients ( 20 OP and 20 IP Patients). The primary outcome will be to evaluate the therapeutic effectiveness  of  Siddha herbal Poora Maathirai in the management of Uthiravatha suronitham(Rheumatoid arthritis).The secondary outcome will be to collect various Siddha literatures and modern journals for literature review of Uthiravatha suronitham, to perform physicochemical, phytochemical, bio chemical analysis of Poora Maathirai, to evaluate safety profile for acute and sub-acute toxicity of -Poora Maathirai, to evaluate pharmacological activities of Poora maathirai, to study other cofactors related to disease like age, sex, dietary habits, family history, and socioeconomic status, to study about the prevalence of Uthiravatha suronitham relation with diet and lifestyleto evaluate Siddha parameters (including Envagai thervu, Neerkuri-Neikuri) for Uthiravatha suronitham during trial period, to evaluate Dhegi of Uthiravatha suronitham patients, to evaluate modern parametric changes in Uthiravathasuronitham, to assess the quality of life  of Uthiravatha suronitham  patients, to document Bio statistical analysis.

 

 
Close